Manufacturers Life Insurance Company, The Neoleukin Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 20, 2022	SELL	$1.72 - $5.23 $34,608 - $105,232	-20,121 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$4.65 - $7.75 $39,715 - $66,192	8,541 Added 73.76%	20,121 $97,000
Q3 2021 Nov 12, 2021	SELL	$6.05 - $9.66 $59,102 - $94,368	-9,769 Reduced 45.76%	11,580 $84,000
Q2 2021 Aug 12, 2021	BUY	$9.23 - $13.12 $21,422 - $30,451	2,321 Added 12.2%	21,349 $197,000
Q1 2021 May 03, 2021	SELL	$11.26 - $15.78 $8,073 - $11,314	-717 Reduced 3.63%	19,028 $234,000
Q4 2020 Feb 12, 2021	BUY	$10.17 - $14.56 $21,438 - $30,692	2,108 Added 11.95%	19,745 $278,000
Q2 2020 Aug 10, 2020	BUY	$9.95 - $17.05 $175,488 - $300,710	17,637 New	17,637 $267,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.